J&J Opioid Trial in Oklahoma Gets Underway

Drug Industry Daily
Opening statements began on Tuesday in Oklahoma’s trial against Johnson & Johnson for the company’s alleged role in the opioid crisis—just two days after the state’s Attorney General Mike Hunter announced a settlement agreement with the other remaining defendant, Teva Pharmaceuticals, for $85 million.

To View This Article:


Subscribe To Drug Industry Daily